PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN

Title:

PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN

Document Type and Number:

WIPO Patent Application WO/2017/028814

Kind Code:

A1

Abstract:

This application provides an oral pharmaceutical composition in a solid form comprising amlodipine or a pharmaceutically acceptable salt thereof, a low dose range of dextromethorphan or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients. The composition is useful for treating hypertension.

More Like This:

JP2017137346	(R)-N-METHYLNALTREXONE, PROCESSES FOR ITS SYNTHESIS AND ITS PHARMACEUTICAL USE
JP2019023227	EGFR TARGETED THERAPY OF NEUROLOGICAL DISORDERS AND PAIN

Inventors:

SUNG KUO-CHUN (CN)
CHEN CHUN-LIANG (CN)
CHEN PEI (CN)
LIN CHI-CHENG (CN)

Application Number:

PCT/CN2016/096028

Publication Date:

February 23, 2017

Filing Date:

August 19, 2016

Export Citation:

Click for automatic bibliography generation Help

Assignee:

TSH BIOPHARM CORP LTD (CN)
HANDA PHARMACEUTICALS INC (CN)

International Classes:

A61K31/485; A61K9/12; A61K31/44

Foreign References:

CN102869360A	2013-01-09
CN1686121A	2005-10-26

Other References:

MEILING CHANG ET AL.: "Content determination of dextromethorphan hydrobromide tablets by HPLC", CHINESE MEDICINE MODERN DISTANCE EDUCATION OF CHINA, vol. 9, no. 15, 31 August 2011 (2011-08-31), pages 147, ISSN: 1672-2779

Attorney, Agent or Firm:

BEIJING SANYOU INTELLECTUAL PROPERTY AGENCY LTD. (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: A COMPOSITION FOR REDUCING LUNG AND/OR SYSTEMIC INFLAMMATION ASSOCIATED WITH PM2.5 EXPOSURE AND THE ...

Next Patent: ENERGY COLLECTING MODULE FOR SMART WATCH AND SMART WATCH